Avanos Medical Inc Cash Flow Reinvestment Rate
Avanos Medical Inc cash flow reinvestment rate. Avanos Medical Inc (AVNS) has a Cash Flow Reinvestment Rate of 0.24x as of December 2025, reinvesting $6.90 Million (capex $6.90 Million ) from operating cash flow of $28.20 Million. Explore Avanos Medical Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Avanos Medical Inc (2011–2025)
Cash flow reinvestment rate of Avanos Medical Inc from 2011 to 2025. Historical reinvestment intensity for Avanos Medical Inc across 12 annual periods. Explore AVNS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Avanos Medical Inc Cash Flow Reinvestment Rate by Year (2011–2025)
Avanos Medical Inc cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Avanos Medical Inc. For the full cash flow conversion analysis, see AVNS cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | $31.60 Million | $74.70 Million | $31.60 Million | ▼ -6.0% |
| 2024 | 0.45x | $45.30 Million | $100.70 Million | $17.80 Million | ▼ -82.2% |
| 2023 | 2.53x | $82.10 Million | $32.40 Million | $17.80 Million | ▲ +48.9% |
| 2022 | 1.70x | $154.70 Million | $90.90 Million | $19.30 Million | ▲ +253.7% |
| 2021 | 0.48x | $42.00 Million | $87.30 Million | $21.00 Million | ▼ -19.6% |
| 2017 | 0.60x | $86.30 Million | $144.20 Million | $43.20 Million | ▼ -50.9% |
| 2016 | 1.22x | $230.00 Million | $188.80 Million | $29.10 Million | ▲ +68.9% |
| 2015 | 0.72x | $70.40 Million | $97.60 Million | $70.40 Million | ▲ +35.9% |
| 2014 | 0.53x | $78.50 Million | $147.90 Million | $78.50 Million | ▲ +142.4% |
| 2013 | 0.22x | $49.00 Million | $223.80 Million | $49.00 Million | ▲ +8.7% |
| 2012 | 0.20x | $40.80 Million | $202.60 Million | $40.80 Million | ▼ -29.2% |
| 2011 | 0.28x | $39.70 Million | $139.60 Million | $39.70 Million | — |